Skip to main content

Table 5 Clinical information of UCEC patients for OS obtained from TCGA database

From: Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma

Variables

UCEC

N = 521(%)

Age

64(57,71)

Stage

 

 Stage I–II

374(71.8%)

 Stage III–IV

147(28.2%)

Grade

 

 G1–2

212(40.7%)

 G3–4

309(59.3%)

Histologic type

 

 Endometrioid

388(74.5%)

 Mixed & serous

133(25.5%)

Risk

 

 Low

261(50.1%)

 High

260(49.9%)